Promea Therapeutics Private Limited

Promea Therapeutics Private Limited - healthcare in Patancheru, Telangana, India. FY 2026 financials and compliance.
CIN U24304TG2017PTC118617 Incorporated 31 July 2017 ROC Hyderabad HQ Patancheru, Telangana, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2023
₹56.78 Cr
▲ 98.06% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.86 Cr
Issued & subscribed
Open charges
₹58.19 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
174
Latest available

About Promea Therapeutics Private Limited

Data last updated: 09 February 2026

Promea Therapeutics Private Limited is a private limited company based in Patancheru, Telangana, India, recognised as a startup by DPIIT. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 31 July 2017, the company has been in operation for over 9 years.

Registered with ROC Hyderabad under CIN U24304TG2017PTC118617.

Capital: an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.86 Cr. It is led by directors Rajesh Reddy Tummuru and Pooja Aakanksha Gaddam.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: M4 Medical Device Park, Patancheru, Telangana.

As per the financials filed for FY 2023, the company reported a revenue of ₹56.78 Cr, a growth of 98.06% compared to the previous year.

The company has a workforce of approximately 174 employees as per the latest available data.

The company is associated with 1 brand - Promea Therapeutics. As per MCA filings, the company has open charges of ₹58.19 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website promea.in.

Company Details of Promea Therapeutics Private Limited
CIN U24304TG2017PTC118617
Registration Number 118617
Incorporation Date 31 July 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Plot No. M4 Medical Device Park, Sultanpur (V), Patancheru, Telangana, India – 502319
  • Industry
    Healthcare, Medical & Laboratory Equipment
Company report
Promea Therapeutics Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Promea Therapeutics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Promea Therapeutics Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Promea Therapeutics Private Limited

Promea Therapeutics Private Limited operates one associated brand: Promea Therapeutics. These brands represent Promea Therapeutics Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Life science products and diagnostics are manufactured by the company. promea.in

Competitors & Alternatives of Promea Therapeutics Private Limited

Brands and companies operating in the same space as Promea Therapeutics Private Limited include GE Healthcare, Medtronic, Boston Scientific and 7 more.

Competitor Description Location Founded
GE Healthcare GE Healthcare Materials management solutions are provided for healthcare organizations. Chicago, United States, United States 1892
Medtronic Medtronic Medical equipment for treating over 30 chronic diseases is developed. Minneapolis, United States, United States 1949
Boston Scientific Boston Scientific Wide range of medical devices Marlborough, United States, United States 1979
Johnson & Johnson Johnson & Johnson Healthcare solutions are provided by Johnson & Johnson globally. New Brunswick, United States, United States 1886
Hologic Hologic Diagnostic and surgical products for women's healthcare are provided. Marlborough, United States, United States 1985
CONMED CONMED Surgical instruments are manufactured for multiple therapeutic areas. Utica, United States, United States 1987
Commure Commure Complex healthcare challenges are addressed through technology solutions by Commure. San Francisco, United States, United States 2016
Coherent Coherent Laser-based and photonics products are manufactured for multiple applications. Santa Clara, United States, United States 1966
Baxter Baxter Biosciences, medication delivery, and renal products are developed and marketed. Deerfield, United States, United States 1931
Danaher Danaher Dental equipment and medical instruments are manufactured for therapeutic areas. - 1969

Business Activity of Promea Therapeutics Private Limited

Promea Therapeutics Private Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Promea Therapeutics Private Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Promea Therapeutics Private Limited

Promea Therapeutics Private Limited is audited by akasam & associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
akasam & associates Locked Locked Locked
Premium access

Complete auditor history for Promea Therapeutics Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Promea Therapeutics Private Limited

Promea Therapeutics Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rajesh Reddy Tummuru Director 09 Oct 2017 8 Years 9 Months Current
Pooja Aakanksha Gaddam Director 31 Jul 2017 8 Years 11 Months Current

Financials of Promea Therapeutics Private Limited FY 2025 filings available

Promea Therapeutics Private Limited reported revenue of ₹56.78 Cr (up 98.06% YoY) for FY 2023.

Revenue · FY 2023
₹56.78 Cr ▲ 98.06%
Premium access

Ten-year financial statements for Promea Therapeutics Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Promea Therapeutics Private Limited

Premium access

Shareholding and ownership data for Promea Therapeutics Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Promea Therapeutics Private Limited

Open charges
₹58.19 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹56.16 Cr
Axis Bank Limited₹2.03 Cr
Latest charge details
DateLenderAmountStatus
11 Jun 2025 Axis Bank Limited ₹28 Lakh Open
01 Jul 2024 Others ₹36.08 Cr Open
29 Dec 2022 Axis Bank Limited ₹1.75 Cr Open
24 May 2021 Others ₹20.08 Cr Open

Total charge records: 4 View all charges

Employees and EPFO Compliance at Promea Therapeutics Private Limited

Promea Therapeutics Private Limited has a workforce of 174 employees as of Apr 06, 2024.

Employee count
174
Active EPFO establishments
1
Employee growth
16.78%
Premium access

Employee and EPFO history for Promea Therapeutics Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Promea Therapeutics Private Limited

Premium access

GST registrations and filing compliance for Promea Therapeutics Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Promea Therapeutics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Promea Therapeutics Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Promea Therapeutics Private Limited

Premium access

MSME payment history for Promea Therapeutics Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Promea Therapeutics Private Limited

Premium access

Corporate group structure for Promea Therapeutics Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Promea Therapeutics Private Limited

Premium access

MCA filings and documents for Promea Therapeutics Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Promea Therapeutics Private Limited

Activity
30 Sep 2025
Promea Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
11 Jun 2025
A charge with Axis Bank Limited amounted to Rs. 0.28 Cr with Charge ID 101180880 was registered on 11 Jun 2025.
Charges
28 May 2025
A charge with Others of Rs. 36.08 Cr registered on 01 Jul 2024 with Charge ID 100955463 was modified on 28 May 2025.
Activity
31 Mar 2025
Promea Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
30 Jan 2025
A charge with Others of Rs. 20.08 Cr registered on 24 May 2021 with Charge ID 100470484 was modified on 30 Jan 2025.
Charges
01 Jul 2024
A charge with Others amounted to Rs. 36.08 Cr with Charge ID 100955463 was registered on 01 Jul 2024.

Frequently Asked Questions about Promea Therapeutics Private Limited

Promea Therapeutics Private Limited is an active private limited company in the healthcare sector based in Patancheru, Telangana, India. It was incorporated on 31 July 2017 (9+ years old) and is registered under CIN U24304TG2017PTC118617. The company has 174 employees.

Promea Therapeutics Private Limited reported revenue of ₹56.78 Cr for FY 2023 (up 98.06% YoY).

The current directors of Promea Therapeutics Private Limited are:

The primary industry of Promea Therapeutics Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.

Yes, Promea Therapeutics Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Promea Therapeutics Private Limited can be reached at the registered office: Plot No. M4 Medical Device Park, Sultanpur V, Patancheru, Telangana, India – 502319, or through the website promea.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available